These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10733604)
21. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties. Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808 [TBL] [Abstract][Full Text] [Related]
22. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
23. Studies of the antagonist actions of (RS)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid (ATPO) on non-NMDA receptors in cultured rat neurones. Dai WM; Ebert B; Madsen U; Lambert JD Br J Pharmacol; 1998 Dec; 125(7):1517-28. PubMed ID: 9884081 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173. Catarzi D; Colotta V; Varano F; Filacchioni G; Galli A; Costagli C; Carlà V J Med Chem; 2001 Sep; 44(19):3157-65. PubMed ID: 11543685 [TBL] [Abstract][Full Text] [Related]
25. Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones. Thomas NK; Clayton P; Jane DE Eur J Pharmacol; 1997 Nov; 338(2):111-6. PubMed ID: 9455991 [TBL] [Abstract][Full Text] [Related]
26. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Kristensen BW; Noraberg J; Zimmer J Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227 [TBL] [Abstract][Full Text] [Related]
27. Excitatory amino acid receptor antagonists: resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA). Johansen TN; Frydenvang K; Ebert B; Madsen U; Krogsgaard-Larsen P Chirality; 1997; 9(5-6):529-36. PubMed ID: 9329180 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO). Bjerrum EJ; Kristensen AS; Pickering DS; Greenwood JR; Nielsen B; Liljefors T; Schousboe A; Bräuner-Osborne H; Madsen U J Med Chem; 2003 May; 46(11):2246-9. PubMed ID: 12747796 [TBL] [Abstract][Full Text] [Related]
29. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology. Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of the isomers of the GluR-specific agonist ATPA. Curry K; Pajouhesh H Can J Physiol Pharmacol; 1998 Jun; 76(6):690-2. PubMed ID: 9923408 [TBL] [Abstract][Full Text] [Related]
32. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
33. Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid. Møller EH; Egebjerg J; Brehm L; Stensbøl TB; Johansen TN; Madsen U; Krogsgaard-Larsen P Chirality; 1999; 11(10):752-9. PubMed ID: 10561704 [TBL] [Abstract][Full Text] [Related]
37. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Pittaluga A; Bonfanti A; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187 [TBL] [Abstract][Full Text] [Related]
38. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA). Johansen TN; Ebert B; Falch E; Krogsgaard-Larsen P Chirality; 1997; 9(3):274-80. PubMed ID: 9176992 [TBL] [Abstract][Full Text] [Related]
39. Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-D-aspartate receptors. Garcia MM; Anderson AT; Edwards R; Harlan RE Neuroscience; 2003; 119(3):787-94. PubMed ID: 12809699 [TBL] [Abstract][Full Text] [Related]
40. N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid. Madsen U; Frydenvang K; Ebert B; Johansen TN; Brehm L; Krogsgaard-Larsen P J Med Chem; 1996 Jan; 39(1):183-90. PubMed ID: 8568805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]